O3-4 First-line tislelizumab plus chemotherapy in gastric/gastroesophageal junction cancer: RATIONALE-305 Asian Subgroup
Title:
O3-4 First-line tislelizumab plus chemotherapy in gastric/gastroesophageal junction cancer: RATIONALE-305 Asian Subgroup
Author:
Kato, K. Bai, Y. Shi, J. Lee, K. Wang, J. Pan, H. Rha, S. Zhang, R. Hirano, H. Yamaguchi, K. Guo, Z. Ba, Y. Yang, L. Tsukuda, H. Xu, Y. Sheng, T. Yang, S. Li, L. Oh, D. Xu, R.